LOOK AT THIS IF YOU'RE INTERESTED IN:
Understanding the challenges and risks associated with decreasing demand for COVID-19 vaccination in Central and West Asia.
HOW YOU CAN USE THIS MATERIAL:
Countries need to adopt different strategies across each of these demand phases to ensure effective use and minimal wastage of COVID-19 vaccines. Stakeholders can use the risks, challenges, and strategies described in this paper to determine which demand phase their country is currently in and tailor interventions to ensure vaccine uptake.
During the early stages of COVID-19 vaccination programmes, the rate of vaccine uptake was determined by number of COVID-19 vaccines approved for use and the manufacturing capacity of the manufacturers of these vaccines. It is a very different situation in 2022, where COVID-19 vaccination coverage is no longer determined by access to supply and manufacturers are reducing or stopping production of vaccines completely. Uptake of COVID-19 vaccination in 2022 is dependent on complex issues like vaccine hesitancy. This paper focuses on the Central and West Asia region, where the authors have been supporting COVID-19 vaccination programmes across seven countries in this region. This paper outlines and describes the different phases of demand for COVID-19 vaccination, as well as the risks and strategies to consider in each of these phases.
There have been three distinct demand phases for the COVID-19 vaccine since first administrations in December 2020.
The first phase was defined by high demand and low supply, the second phase as a period of high demand and high supply, and the third phase as a period of high supply and low demand.
Countries need to adopt different strategies across each of these demand phases to ensure effective use and minimal wastage of COVID-19 vaccines.
The extent to which vaccine hesitancy and vaccine nationalism feature in different regions is dependent on the demand phase being experienced.